Company News: Curetis Publishes Interim Report for the First Half-Year 2018

Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that further to its Half-Year Results Announcement made on 14 August 2018 it has filed its interim report for the first half year of 2018, including the half-year financial statements prepared in accordance with IAS 34 “Interim Financial Reporting, (the “Interim Statements”) with the Autoriteit Financiële Markten (the “AFM”) in the Netherlands today.

The Interim Statements are available through the AFM website and also the Company’s website: